Type I interferons in pancreatic cancer and development of new therapeutic approaches

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Pancreas Cancer 100%
• Malignant Neoplasm 66%
• Interferon Type I 66%
• Tumor Microenvironment 33%
• Immunosuppressive Agent 33%
• Immunotherapy 33%
• Enalapril Maleate 33%

Immunology and Microbiology

• Interferon Type I 66%
• Innate Immune System 33%
• Adaptive Immune System 33%
• Immune Response 33%
• Immunotherapy 33%
• Immunosuppressive Drug 33%
• RIG-I 33%
• Development 33%
• Spectrum 33%
• Comprehension 33%
• Introspection 33%
• Conjugate 33%